Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2021 3
2022 6
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Clinical and pathological predictors of persistent T1 HG at second resection.
Gobbo A, Fasulo V, Contieri R, Uleri A, Avolio PP, Frego N, Lughezzani G, Saitta C, Taverna G, Zanoni M, Mancon S, Colombo P, Valeri M, Saita A, Lazzeri M, Buffi NM, Hurle R, Casale P. Gobbo A, et al. Among authors: avolio pp. Urologia. 2023 Aug;90(3):482-490. doi: 10.1177/03915603231181619. Epub 2023 Jun 21. Urologia. 2023. PMID: 37341094 Free PMC article.
Xpert Bladder Cancer Monitor May Avoid Cystoscopies in Patients Under "Active Surveillance" for Recurrent Bladder Cancer (BIAS Project): Longitudinal Cohort Study.
Fasulo V, Paciotti M, Lazzeri M, Contieri R, Casale P, Saita A, Lughezzani G, Diana P, Frego N, Avolio PP, Colombo P, Elefante GM, Guazzoni G, Buffi NM, Bates M, Hurle R. Fasulo V, et al. Among authors: avolio pp. Front Oncol. 2022 Jan 27;12:832835. doi: 10.3389/fonc.2022.832835. eCollection 2022. Front Oncol. 2022. PMID: 35155263 Free PMC article.
Prospective evaluation of the role of imaging techniques and TMPRSS2:ERG mutation for the diagnosis of clinically significant prostate cancer.
Lazzeri M, Fasulo V, Lughezzani G, Benetti A, Soldà G, Asselta R, De Simone I, Paciotti M, Avolio PP, Contieri R, Saitta C, Saita A, Hurle R, Guazzoni G, Buffi NM, Casale P. Lazzeri M, et al. Among authors: avolio pp. Front Oncol. 2022 Sep 6;12:968384. doi: 10.3389/fonc.2022.968384. eCollection 2022. Front Oncol. 2022. PMID: 36147926 Free PMC article.
Male awareness of prostate cancer risk remains poor in relatives of women with germline variants in DNA-repair genes.
Fasulo V, Buffi N, Chiarelli G, Lughezzani G, Zuradelli M, Ripamonti CB, Barile M, Bianchi P, Benetti A, Paciotti M, Uleri A, Avolio PP, Saita A, Hurle R, Maura F, Germagnoli L, Asselta R, Soldà G, Casale P, Lazzeri M. Fasulo V, et al. Among authors: avolio pp. BJUI Compass. 2023 Jun 21;4(6):738-745. doi: 10.1002/bco2.252. eCollection 2023 Nov. BJUI Compass. 2023. PMID: 37818031 Free PMC article.
Diagnostic performance of microUltrasound at MRI-guided confirmatory biopsy in patients under active surveillance for low-risk prostate cancer.
Maffei D, Fasulo V, Avolio PP, Saitta C, Paciotti M, De Carne F, Colombo P, Pasini L, De Zorzi SZ, Saita A, Hurle R, Lazzeri M, Guazzoni GF, Casale P, Buffi NM, Lughezzani G. Maffei D, et al. Among authors: avolio pp. Prostate. 2023 Jun;83(9):886-895. doi: 10.1002/pros.24532. Epub 2023 Apr 4. Prostate. 2023. PMID: 36960788
Could We Safely Avoid a Second Resection in Selected Patients With T1 Non-Muscle-Invasive Bladder Cancer? Preliminary Results of Cost-Effectiveness Study From HUmanitas New Indications for ReTUR (HuNIRe) Multicenter Prospective Trial.
Contieri R, Lughezzani G, Buffi NM, Taverna G, Giacobbe A, Micheli E, Barra S, Colombo P, Vanni E, Guazzoni G, Lazzeri M, Hurle R; HuNIRe Study Group. Contieri R, et al. Front Oncol. 2022 May 18;12:879399. doi: 10.3389/fonc.2022.879399. eCollection 2022. Front Oncol. 2022. PMID: 35664755 Free PMC article.
24 results